Salarius Pharmaceuticals Inc (SLRX)
Market Closed
21 Apr, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
0. 69
+0.01
+1.92%
$
2.13M Market Cap
- P/E Ratio
0% Div Yield
72,400 Volume
-5.32 Eps
$ 0.68
Previous Close Day Range
0.64 0.7
Year Range
0.45 7.2
Earnings results expected in 19 days
Want to track SLRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| SLRX Salarius Pharmaceuticals Inc 12 May 2025 (19 Days) | | - Cons. EPS | - EPS |
| SLRX Salarius Pharmaceuticals Inc 20 Mar 2025 | | - Cons. EPS | - EPS |
| SLRX Salarius Pharmaceuticals Inc 7 Nov 2024 | | - Cons. EPS | - EPS |
| SLRX Salarius Pharmaceuticals Inc 9 Aug 2024 | | - Cons. EPS | - EPS |
| SLRX Salarius Pharmaceuticals Inc 8 Aug 2024 | | - Cons. EPS | - EPS |
| SLRX Salarius Pharmaceuticals Inc 13 Jun 2024 | | - Cons. EPS | - EPS |
| SLRX Salarius Pharmaceuticals Inc 13 May 2024 | | - Cons. EPS | - EPS |
| SLRX Salarius Pharmaceuticals Inc 25 Mar 2024 | | - Cons. EPS | - EPS |
| SLRX Salarius Pharmaceuticals Inc 22 Mar 2024 | | - Cons. EPS | - EPS |
| SLRX Salarius Pharmaceuticals Inc 9 Nov 2023 | | - Cons. EPS | - EPS |
2025 © Marketlog. All Rights Reserved.
